Abstract
We examined synaptic plasticity at intrasuprachiasmatic nucleus (SCN) gamma-aminobutyric acid (GABA)ergic synapses by measuring the paired-pulse ratio between pairs of evoked inhibitory postsynaptic currents (IPSCs). Interstimulus intervals were chosen to represent the range of spontaneous action potential firing frequencies found in SCN neurons. A majority of synapses studied during the day exhibited paired-pulse depression (PPD), whereas a majority of synapses studied during the night showed no PPD. Two types of PPD were found. Type 1 PPD expresses the greatest inhibition at shorter interstimulus intervals, is predominant in the early morning and is likely to be a result of vesicle depletion. Type 2 showed the greatest inhibition at interstimulus intervals between 175 and 225 ms, is found throughout the day yet rarely at night and is likely to be a result of a Ca(2+)-dependent mechanism that is independent of pertussis toxin-sensitive G-proteins. Thus, multiple mechanisms of synaptic plasticity modulate intra-SCN communication throughout the diurnal cycle.
Publication types
-
Comparative Study
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
2-Amino-5-phosphonovalerate / pharmacology
-
6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
-
Analysis of Variance
-
Animals
-
Baclofen / analogs & derivatives*
-
Baclofen / pharmacology
-
Calcium / metabolism
-
Circadian Rhythm / physiology*
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Ethylmaleimide / pharmacology
-
Excitatory Amino Acid Antagonists / pharmacology
-
GABA Antagonists
-
In Vitro Techniques
-
Magnesium / metabolism
-
Male
-
Membrane Potentials / drug effects
-
Models, Neurological
-
Neural Inhibition / drug effects
-
Neural Inhibition / physiology
-
Neuronal Plasticity / physiology*
-
Patch-Clamp Techniques
-
Rats
-
Rats, Sprague-Dawley
-
Suprachiasmatic Nucleus / drug effects
-
Suprachiasmatic Nucleus / physiology*
-
Synapses / drug effects
-
Synapses / physiology*
-
Time Factors
-
gamma-Aminobutyric Acid / metabolism*
Substances
-
Enzyme Inhibitors
-
Excitatory Amino Acid Antagonists
-
GABA Antagonists
-
gamma-Aminobutyric Acid
-
6-Cyano-7-nitroquinoxaline-2,3-dione
-
2-Amino-5-phosphonovalerate
-
Baclofen
-
Magnesium
-
saclofen
-
Ethylmaleimide
-
Calcium